Mexico City – Foreign Minister Marcelo Ebrard on Saturday reported through his Twitter account that the Moderna vaccine, which has a similar technological profile to that of Pfizer, will soon be approved in Mexico.
According to the World Health Organization, Moderna is a messenger RNA (mRNA) vaccine that requires two doses. On December 18, 2020, the U.S. Food and Drug Administration (FDA) authorized the emergency use of the Modern vaccine in people over 18 years of age.
In June 2021, the pharmaceutical company announced that its COVID-19 vaccine is extremely effective against the highly contagious Delta variant, which is becoming the dominant strain in the US, France, Germany, South Africa and other nations.
The Foreign Minister tweeted that this presents “more and better options” for Mexico’s vaccination plan for the remainder of the year and the one already designed for 2022.
In addition, he reported that so far Mexico has received a total of 59,972,335 million doses from 6 pharmaceutical companies that have sent shipments to the country since December 23, 2020. This includes the 585,000 Pfizer vaccines received early Monday morning.
Add to this the 5,582,540 Cansino Biologics and 8,729,300 AstraZeneca vaccines that have been packaged in Mexico, and the total number of vaccines that have been made available to the Mexican people to date is 74,284,175.
This is in line with the objective of the Mexican Government, which has reiterated on several occasions its goal of having everyone over 18 years of age vaccinated by October, at least with a first dose.